◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

ELEVANCE HEALTH, INC.

ELEVANCE HEALTH, INC.
ELV CIK: 1156039 Finance & Insurance
INDIANAPOLIS, IN
Loading...
Price History
Market Data
Market Cap86.70B
P/E Ratio-
P/B Ratio1.98
EPS-
Dividend Yield1.51%
D/E Ratio1.77
Current Ratio1.54
CurrencyUSD
Key Financial Metrics
199.12B
Revenue
5.66B
Net Income
-
EPS (Diluted)
6.60B
Free Cash Flow
Profitability
Gross Margin 89.4%
Operating Margin -
Net Profit Margin 2.8%
EBITDA -
Returns & Efficiency
Return on Assets (ROA) 4.7%
Return on Equity (ROE) 12.9%
Dividend Yield 1.51%
EPS -
Financial Health
Total Assets 121.49B
Total Debt 32.05B
Debt to Equity 1.77x
Current Ratio 1.54
Insider Trading Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report

Loading...

10-Q
Quarterly Report

Loading...

8-K
Recent News

Loading...

Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
HQINDIANAPOLIS, IN
Fiscal Year2025
Peers
322.71B
P/E: --
74.58B
P/E: --
74.58B
P/E: --
32.05B
P/E: --
22.65B
P/E: --
10.94B
P/E: --
10.94B
P/E: --
4.76B
P/E: --
Financial Statistics
Valuation
Market Cap$86.70B
P/E Ratio (TTM)-
Price to Book1.98
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin89.4%
Operating Margin-
Net Margin2.8%
ROE12.9%
ROA4.7%
Leverage & Liquidity
Debt to Equity1.77
Current Ratio1.54
Total Debt$32.05B
Total Assets$121.49B
Stockholders' Equity$43.88B
Income Statement (FY 2025)
Revenue$199.12B
Gross Profit$177.95B
Operating Income-
Net Income$5.66B
EPS (Diluted)-
Cash Flow (FY 2025)
Free Cash Flow$6.60B
Cash & Equivalents$9.49B
Revenue Growth12.5%
SEC Filings by Category
Insider Trading Activity
Neutral 0 Buys $0 0 Sales $0 0 Exercises $0 Net: $0
InsiderTitleDateTypeSharesPriceValue
Company Information
Business Address220 VIRGINIA AVENUE
INDIANAPOLIS, IN 46204
Phone8003311476
IncorporatedIN, US
EIN352145715
Fiscal Year End1231
Shares Outstanding220.70M
Stockholders' Equity$43.88B
Cash & Equivalents$9.49B
Recent Filings View All
SCHEDULE 13G Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-29
Local
8-K Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-22
Local
10-Q Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-04-22
Local
PX14A6G PX14A6G Filing
SEC regulatory filing
Filed: 2026-04-07
Local
SCHEDULE 13G/A Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-03-26
Local
8-K Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-10
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-09
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-06
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
Loading...

Loading management data...

Loading...

Loading board of directors...

Loading...

Loading institutional holders...

Loading...

Loading short interest data...

Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
Company NameELEVANCE HEALTH, INC.
TickerELV
Exchange--
SectorFinance & Insurance
Industry--
HeadquartersINDIANAPOLIS, IN
Fiscal Year2025
Financial Summary
Market Cap86.70B
Revenue199.12B
Net Income5.66B
P/E Ratio-
EPS-
Net Margin2.8%
ROE12.9%
Dividend Yield1.51%
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...